Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cement-Free Hip Replacement System

By HospiMedica staff writers
Posted on 12 Jun 2006
A new acetabular hip replacement system is intended to relieve pain and increase functionality in the hip without the use of cement.

In theory, cement-free joint replacements are expected to reduce the chance of infection and loosening of the prosthesis, which are the two major complications of hip replacement surgery. More...
The Surpass acetabular system, developed by Stelkast (McMurray, PA, USA), is a ceramic-on-ceramic artificial hip replacement system designed for use in primary total hip arthroplasty due to noninflammatory degenerative joint diseases such as osteoarthritis, avascular necrosis, congenital hip dysplasia, and traumatic arthritis. The system has been cleared by the U.S. Food and Drug Administration (FDA).

The prosthetic device consists of a metal hip stem that is placed into a hole drilled in the end of the thigh bone, a femoral head that attaches to the top of the hip stem, a ceramic insert that the femoral head fits into, and an acetabular shell that is implanted into the pelvis. The metal hip stem and acetabular shell are intended for cement-free use and are held in place by a press-fit into the surrounding bone. Porous surface coatings on some metal components aid in long-term fixation by allowing tissue ingrowth.

Use of the device is contraindicated in patients with insufficient quantity or quality of bone to allow its proper insertion and fixation, insufficient soft-tissue integrity to provide adequate stability, muscle laxity or inadequate soft tissue for proper function and healing, neuromuscular disorders that do not allow control of the affected joint, active joint infections, or chronic systemic infections, obesity, and skeletal immaturity.



Related Links:
Stelkast

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.